Covestor LTD Axsome Therapeutics, Inc. Transaction History
Covestor LTD
- $160 Million
- Q3 2024
A detailed history of Covestor LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 127 shares of AXSM stock, worth $13,431. This represents 0.01% of its overall portfolio holdings.
Number of Shares
127
Previous 1,007
87.39%
Holding current value
$13,431
Previous $81,000
86.42%
% of portfolio
0.01%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
332Shares Held
38.3MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$443 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$423 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$349 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$250 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$111 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.53B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...